PedAM
Pediatric Disease Annotations & Medicines
| Disease | neutropenia |
| Phenotype | C0007131|nsclc |
| Sentences | 2 |
| PubMedID- 26448029 | Erlotinib plus ct or alone relative to ct is associated with significantly decreased risks of neutropenia and leukopenia in patients with advanced nsclc (rr, 0.38; 95% ci, 0.21–0.71; p = 0.00; incidence: 9.9 vs. 35.2%) and (rr, 0.32; 95% ci, 0.11–0.93; p = 0.04; incidence: 3.5 vs. 11.6%), respectively. |
| PubMedID- 23882424 | Di maio et al.10 showed that nsclc patients with severe neutropenia had slightly better chance of survival than those without neutropenia. |
Page: 1